JP Morgan Investment Insulates Limeglass Start-Up Amid Coronavirus

The research start-up is growing its team and is in discussions with clients, despite Covid-19 disruption, after the bank acquired a stake.

plant with money

Research start-up Limeglass is riding out the coronavirus storm, thanks to investment from JP Morgan.

Limeglass announced late last year that the bank had acquired an undisclosed stake, and the start-up has since used the funding to hire more people and improve its product, which filters financial research documents to find the most relevant information.

“The investment was a game-changer for us. Clearly, it is helping us through [the coronavirus pandemic], but even before that, we were able

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

CME: CFTC OKs clearing move to Google Cloud

The CFTC has given the Chicago-based exchange approval to run its clearing and settlement infrastructure on the Google Cloud Platform, while the exchange and vendor have extended their partnership to last until at least 2037.

Once a blockchain cheerleader, Axoni changes its playbook

The fintech, whose origins can be traced back to the genesis of capital markets’ complicated flirtation with DLT, has largely ditched the tech as the foundation of its data synchronization offering, opting for more familiar territory.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here